Framework agreement for CAR-T cell therapy active ingredients
Oryginalny tytuł ogłoszenia
Italy – Antineoplastic and immunomodulating agents – GARA EUROPEA A PROCEDURA APERTA PER LA FORNITURA, IN ACCORDO QUADRO MULTIFORNITORE, DI PRINCIPI ATTIVI PER TERAPIE CON CELLULE CAR-T DESTINATE A PAZIENTI IN CARICO ALL’AZIENDA ULSS N. 8 BERICA
Ocena szansy
Skąd ta ocena?
Szansa
30 / 100
Złożoność
60 / 100
Czynniki ryzyka
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- EUR 19.4M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 12 MONTH
- Supply of active principles (pharmaceutical substances) for CAR-T cell therapies.
- The products are intended for specific lymphoma indications: DLBCL (2nd and 3rd line), PMBCL (3rd line), and follicular lymphoma (4th line).
Pokaż pełne podsumowanie
This is an open procedure tender for a multi-supplier framework agreement for the supply of active principles for CAR-T cell therapies, intended for patients under the care of Azienda ULSS n. 8 Berica (Italy). The tender is divided into three lots covering specific lymphoma therapies. The procedure is currently suspended due to a complaint (reclamo) as per the XML notice. The estimated total value across lots is €19,401,945. Award is based solely on price. Submission deadline is 2026-07-06 (10:00 or 12:00 – inconsistency noted). Important documents (e.g., ESPD) are required. EU funding status is inconsistent between structured data (EU-funded) and XML notice (no EU funds). The notice is in Italian only.
Ryzyka
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Certifications
- All communications and submissions must be electronic via Sintel or certified email (PEC) for Italian operators, or qualified electronic registered delivery service for...
Administrative
- Registration on the Sintel e-procurement platform (ARIA SPA) is mandatory.
- Tender must be accompanied by the European Single Procurement Document (ESPD) or equivalent.
Wymagania mogą być niepełne.
Kryteria udzielenia
Lot 1
Lot 2
Lot 3
Zamawiający
Lokalizacja
Vicenza, ITA
Strona
Profil zamawiającego
Identyfikator
02441500242
Działalność
Health
Części (3)
LOT-0001
LOTTO 1 - Therapy for adult patients with DLBCL Lymphoma - 2nd Line and Therapy for adult patients with PMBCL Lymphoma - 3rd Line
Supply of active principles for CAR-T therapy for adult patients with DLBCL (2nd line) and PMBCL (3rd line). Framework agreement with a maximum value of €15,936,345, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Szacowana wartość
Czas trwania
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
Lowest price
Uwaga do wartości
Maksymalna wartość umowy ramowej
Pokaż oryginalne dane TED
Oryginalny tytuł części
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
Oryginalny opis TED
LOTTO 1 - Terapia per pazienti adulti con Linfoma DLBCL - 2 Linea e Terapia per pazienti adulti con linfoma PMBCL - 3 linea
LOT-0002
LOTTO 2 - Therapy for adult patients with DLBCL Lymphoma - 3rd Line
Supply of active principles for CAR-T therapy for adult patients with DLBCL (3rd line). Framework agreement with a maximum value of €1,732,800, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Szacowana wartość
Czas trwania
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
Lowest price
Uwaga do wartości
Maksymalna wartość umowy ramowej
Pokaż oryginalne dane TED
Oryginalny tytuł części
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
Oryginalny opis TED
LOTTO 2 - Terapia per pazienti adulti con Linfoma DLBCL - 3 Linea
LOT-0003
LOTTO 3 - Therapy for adult patients with Follicular Lymphoma (FL) - 4th Line
Supply of active principles for CAR-T therapy for adult patients with follicular lymphoma (4th line). Framework agreement with a maximum value of €1,732,800, including a 12-month initial period and an optional 12-month renewal.
EUR 19.4M
Szacowana wartość
Czas trwania
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
Lowest price
Uwaga do wartości
Maksymalna wartość umowy ramowej
Pokaż oryginalne dane TED
Oryginalny tytuł części
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Oryginalny opis TED
LOTTO 3 - Terapia per pazienti adulti con Linfoma follicolare (LF) - 4 linea
Szczegóły zamówienia
- Data publikacji
- 02 Jul 2026
- Języki
- Italian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 456933-2026
Dokumenty (2)
Podobne przetargi
Ocena szansy
Skąd ta ocena?
Szansa
30 / 100
Złożoność
60 / 100
Czynniki ryzyka
The tender notice (XML) indicates the procedure is suspended due to a complaint (reclamo). Potential outcomes: cancella...
EU funding flag differs between structured data (EU-funded) and XML (no-eu-funds). Also, submission deadline time incon...
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications